Literature DB >> 2037012

Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 interleukin 2 receptor subunit.

J Plumas1, V Gruart, D Aldebert, M J Truong, M Capron, A Capron, L Prin.   

Abstract

The expression of interleukin 2 receptor (IL2R) on eosinophils was investigated in patients with hypereosinophilia. Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment. The presence of p55 alpha chain of IL2R (CD25) on purified eosinophils collected from blood of hypereosinophilic patients was detected by flow cytometry. In 10 out of 19 cases, more than 10% of eosinophils were CD25+. Cross-linking studies on enriched eosinophils showed one 64-75-kDa band, consisting of IL2 (15 kDa) cross-linked to the IL2R p55 subunit. In Northern blot analysis the two messenger mRNA (3.5 and 1.5 kb) encoding the IL2R p55 subunit were identified after hybridization with a CD25 cDNA probe. In contrast, the presence of the IL2R p75 subunit was not detected. These data provide preliminary evidence for the expression of a low-affinity receptor for IL2 on in vivo activated eosinophils and raise the question of the role played by this cytokine in eosinophil differentiation and activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2037012     DOI: 10.1002/eji.1830210525

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer.

Authors:  Hiroki Kato; Katsura Kohata; Joji Yamamoto; Satoshi Ichikawa; Mika Watanabe; Kenichi Ishizawa; Ryo Ichinohasama; Hideo Harigae
Journal:  Int J Hematol       Date:  2010-02-05       Impact factor: 2.490

2.  A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophils.

Authors:  Fanny Legrand; Virginie Driss; Gaëtane Woerly; Sylvie Loiseau; Emmanuel Hermann; Jean-Jacques Fournié; Laurent Héliot; Virginie Mattot; Fabrice Soncin; Marie-Lise Gougeon; David Dombrowicz; Monique Capron
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.